DEL-1 promotes macrophage efferocytosis and clearance of inflammation-Reference-Cited by-同舟云学术

DEL-1 promotes macrophage efferocytosis and clearance of inflammation

Published:2018-11-19 Issue:1 Volume:20 Page:40-49
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Kourtzelis Ioannis^ORCID,Li Xiaofei,Mitroulis Ioannis,Grosser Daniel,Kajikawa Tetsuhiro,Wang Baomei,Grzybek Michal,von Renesse Janusz,Czogalla Aleksander,Troullinaki Maria,Ferreira Anaisa,Doreth Christian,Ruppova Klara,Chen Lan-Sun,Hosur Kavita,Lim Jong-Hyung,Chung Kyoung-Jin,Grossklaus Sylvia,Tausche Anne Kathrin,Joosten Leo A. B.^ORCID,Moutsopoulos Niki M.,Wielockx Ben^ORCID,Castrillo Antonio,Korostoff Jonathan M.,Coskun Ünal,Hajishengallis George,Chavakis Triantafyllos^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/s41590-018-0249-1.pdf

Reference69 articles.

1. Fullerton, J. N. & Gilroy, D. W. Resolution of inflammation: a new therapeutic frontier. Nat. Rev. Drug. Discov. 15, 551–567 (2016).

2. Serhan, C. N. Pro-resolving lipid mediators are leads for resolution physiology. Nature 510, 92–101 (2014).

3. Serhan, C. N., Chiang, N. & Dalli, J. The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution. Semin. Immunol. 27, 200–215 (2015).

4. Greenlee-Wacker, M. C. Clearance of apoptotic neutrophils and resolution of inflammation. Immunol. Rev. 273, 357–370 (2016).

5. Birge, R. B. et al. Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer. Cell Death Differ. 23, 962–978 (2016).

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptidyl arginine deiminase-4 inhibitor ameliorates pulmonary fibrosis through positive regulation of developmental endothelial locus-1;International Immunopharmacology;2024-10

2. In silico analysis of DEL-1 and inflammation-related genes in lung squamous cell carcinoma;Immunobiology;2024-09

3. Therapeutic delivery of CCL2 modulates immune response and restores host–microbe homeostasis;Proceedings of the National Academy of Sciences;2024-08-26

4. Developmental endothelial locus 1: the present and future of an endogenous factor in vessels;Frontiers in Physiology;2024-08-09

5. Nischarin inhibits the epithelial-mesenchymal transition process and angiogenesis in breast cancer cells by inactivating FAK/ERK signaling pathway via EGF like repeats and discoidin domains 3;Molecular Biology Reports;2024-07-18